Table 4.
LFD | WD | WD + TMAO | WD + TMAO + L-HFE | WD + TMAO + H-HFE | p value | p for dose effect | |
---|---|---|---|---|---|---|---|
TC (mg/dL) | 673 ± 73b | 1163 ± 156a | 1250 ± 134a | 1177 ± 153a | 1138 ± 133a | < 0.001 | 0.117 |
HDL-C (mg/dL) | 74 ± 20a | 46 ± 15b | 46 ± 20b | 41 ± 19b | 43 ± 13b | 0.016 | 0.745 |
TG (mg/dL) | 131 ± 22b | 216 ± 43a | 226 ± 28a | 255 ± 48a | 224 ± 42a | < 0.001 | 0.143 |
Non-HDL-C (mg/dL) | 600 ± 67b | 1117 ± 154a | 1204 ± 152a | 1136 ± 161a | 1095 ± 130a | < 0.001 | 0.919 |
Non-HDL-C/HDL-C | 8.64 ± 2.27b | 27.06 ± 11.32a | 31.99 ± 15.98a | 31.92 ± 12.74a | 27.30 ± 8.81a | 0.006 | 0.464 |
HDL-C/TC | 0.11 ± 0.03a | 0.04 ± 0.01b | 0.04 ± 0.02b | 0.04 ± 0.02b | 0.04 ± 0.01b | < 0.001 | 0.982 |
Mice were fed a low-fat diet (LFD), a Western diet (WD), or one of the three WDs containing 0.2% TMAO (WD + TMAO), 0.2% TMAO plus 1% hawthorn fruit extract (WD + TMAO + L-HFE), or 0.2% TMAO plus 2% hawthorn fruit extract (WD + TMAO + H-HFE) for 12 weeks. Data are expressed as mean ± SD, n = 8
TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triacylglycerol; Non-HDL-C, non-HDL cholesterol
a,bMeans in the same row with different letters differ significantly at p < 0.05 by one-way ANOVA. p for dose effect was analyzed using ordinary linear regression across WD + TMAO, WD + TMAO + L-HFE, and WD + TMAO + H-HFE groups